Enolase inhibitors as therapeutic leads for Naegleria fowleri infection
PLOS Pathogens · 2024
DOI: 10.1371/journal.ppat.1012412 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, 2024. Verfasst von Jillian E Milanes und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics and Biochemistry, Eukaryotic Pathogens Innovation Center, Clemson University, Clemson, South Carolina, United States of Americ…. Hauptthemen laut MEDLINE: Naegleria fowleri, Central Nervous System Protozoal Infections, Phosphopyruvate Hydratase. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIGMS NIH HHS, NIH HHS.
Abstract (Originalsprache)
Infections with the pathogenic free-living amoebae Naegleria fowleri can lead to life-threatening illnesses including catastrophic primary amoebic meningoencephalitis (PAM). Efficacious treatment options for these infections are lacking and the mortality rate remains >95% in the US. Glycolysis is very important for the infectious trophozoite lifecycle stage and inhibitors of glucose metabolism have been found to be toxic to the pathogen. Recently, human enolase 2 (ENO2) phosphonate inhibitors have been developed as lead agents to treat glioblastoma multiforme (GBM). These compounds, which cure GBM in a rodent model, are well-tolerated in mammals because enolase 1 (ENO1) is the predominant isoform used systemically. Here, we describe findings that demonstrate these agents are potent inhibitors of N . fowleri ENO ( Nf ENO) and are lethal to amoebae. In particular, (1-hydroxy-2-oxopiperidin-3-yl) phosphonic acid (HEX) was a potent enzyme inhibitor (IC 50 = 0.14 ± 0.04 μM) that was toxic to trophozoites (EC 50 = 0.21 ± 0.02 μM) while the reported CC 50 was >300 μM. Molecular docking simulation revealed that HEX binds strongly to the active site of Nf ENO with a binding affinity of –8.6 kcal/mol. Metabolomic studies of parasites treated with HEX revealed a 4.5 to 78-fold accumulation of glycolytic intermediates upstream of Nf ENO. Last, nasal instillation of HEX increased longevity of amoebae-infected rodents. Two days after infection, animals were treated for 10 days with 3 mg/kg HEX, followed by one week of observation. At the end of the one-week observation, eight of 12 HEX-treated animals remained alive (resulting in an indeterminable median survival time) while one of 12 vehicle-treated rodents remained, yielding a median survival time of 10.9 days. However, intranasal HEX delivery was not curative as brains of six of the eight survivors were positive for amoebae. These findings suggest that HEX requires further evaluation to develop as a lead for treatment of PAM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Genetics and Biochemistry, Eukaryotic Pathogens Innovation Center, Clemson University, Clemson, South Carolina, United States of America.
- Department of Cancer Systems Imaging, UT MD Anderson Cancer Center, Houston, Texas, United States of America.
- Sporos Bioventures, Houston, Texas, United States of America.
- Department of Chemistry, Eukaryotic Pathogens Innovation Center, Clemson University, Clemson, South Carolina, United States of America.
- UCB BioSciences, Bainbridge Island, Washington, United States of America.
- Center for Emerging and Re-emerging Infectious Diseases and Seattle Structural Genomics Center for Infectious Disease, Center for Global Infection Disease Research, Seattle Children's Research Institute, Seattle, Washin…
ORCID-Profile: Jillian E Milanes, James C Morris
Förderung
- NIAID NIH HHS
- NIGMS NIH HHS
- NIH HHS
- NCI NIH HHS
- NIH
Zitieren
APA
Milanes, J. E., Yan, V. C., Pham, C. D., Muller, F., Kwain, S., Rees, K. C., Dominy, B. N., Whitehead, D. C., Millward, S. W., Bolejack, M., Shek, R., Tillery, L., Phan, I. Q., Staker, B., Moseman, E. A., Zhang, X., Ma, X., Jebet, A., Yin, X., & Morris, J. C. (2024). Enolase inhibitors as therapeutic leads for Naegleria fowleri infection. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1012412
Vancouver
Milanes JE, Yan VC, Pham CD, Muller F, Kwain S, Rees KC, et al. Enolase inhibitors as therapeutic leads for Naegleria fowleri infection. PLOS Pathogens. 2024. doi:10.1371/journal.ppat.1012412
BibTeX
@article{Milanes2024,
author = {Milanes, Jillian E and Yan, Victoria C and Pham, Cong-Dat and Muller, Florian and Kwain, Samuel and Rees, Kerrick C and Dominy, Brian N and Whitehead, Daniel C and Millward, Steven W and Bolejack, Madison and Shek, Roger and Tillery, Logan and Phan, Isabelle Q and Staker, Bart and Moseman, E Ashley and Zhang, Xiang and Ma, Xipeng and Jebet, Audriy and Yin, Xinmin and Morris, James C},
title = {Enolase inhibitors as therapeutic leads for Naegleria fowleri infection},
journal = {PLOS Pathogens},
year = {2024},
doi = {10.1371/journal.ppat.1012412}
}
EUVIMED